Profound impairment of adaptive immune responses by alkylating chemotherapy - Wikidata - wikimedia - TriplyDB

Profound impairment of adaptive immune responses by alkylating chemotherapy

Profound impairment of adaptive immune responses by alkylating chemotherapy

http://www.wikidata.org/entity/Q36922577

about

How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs Immunotherapy advances for glioblastoma Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses.Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model.CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma Cellular immunotherapy for malignant gliomas.Immunological effects of chemotherapy and radiotherapy against brain tumors.STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.A Review of Immune Therapy in Cancer and a Question: Can Thermal Therapy Increase Tumor Response?Antigen-specific culture of memory-like CD8 T cells for adoptive immunotherapy.Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination.Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival.Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM.Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide.Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide.

P2860

Q26771113-1DB40411-3068-457D-86EB-661AEC40BB27 Q26781522-B8874DDE-67B7-461F-B830-1C80283D6A28 Q26866513-EAEF9A7D-E97E-4ABF-8539-014D3BC020F6 Q27027730-300DD2D5-22E3-4057-A8E6-88B4FA1AC72E Q33606096-285B7F46-F776-4072-B25A-F9D4B37A7D4F Q34457611-451CC931-3992-4C6B-9A7A-ECE0A41B6E00 Q35163556-F94DBF5B-4A45-48EE-8D1B-46E7A0798ADF Q35546240-C3A9D8B1-063D-4B47-A5BA-560B2EDCE917 Q35561280-92D903F1-8DA5-48A2-81A3-9FC287A16A11 Q35594838-D22E6DFF-706F-4FBA-983D-71D5774D7771 Q35657822-5FC382A7-6560-4691-B2C2-C68962C2746B Q36023855-BBD82EF2-6C12-42C1-B30E-224CED947B80 Q36137504-441FFC82-B737-428A-A5E8-AD991826B098 Q36600960-480A156A-958E-4A9F-BA87-4B65A842771C Q37012579-DBFDF53F-40BF-4BD4-BF28-067D8DFE32F6 Q37321033-2BD90773-159F-4A4D-A05D-4CB6971D91EB Q38902169-0E84558D-EEF8-4D33-A981-5543070753B9 Q38947116-08483F8F-6326-441A-8771-73AFC4EEEC45 Q38949322-8C9963A2-6B09-4744-9133-E8F12A3FF90D Q41928232-A303AF54-9385-4167-87CB-35AE19030EFD Q42124330-3EC5195C-6886-41B9-B3AF-C47EDEB5505C Q42177990-84A0CDF1-EE3F-41D6-80DA-8AE1DCB586BD Q42639856-F205E772-47C5-4BF7-AC43-14E340E1AEB8 Q47161862-777868B3-C318-47EB-A3D0-B0596C1284F8 Q48641340-A32A1B41-776A-47E1-ACF1-F0BC299AFF14 Q52597547-ACC13BA1-50CB-443E-9807-EA093FF4039D

P2860

Profound impairment of adaptive immune responses by alkylating chemotherapy

http://www.wikidata.org/entity/Q36922577

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Profound impairment of adaptive immune responses by alkylating chemotherapy

@en

type

label

Profound impairment of adaptive immune responses by alkylating chemotherapy

@en

prefLabel

Profound impairment of adaptive immune responses by alkylating chemotherapy

@en

P1433

Q36922577-965F164A-CAF6-455D-8A0E-9B197D08CCD1

P1476

Q36922577-046FD2D6-5F89-4047-81B0-58B0465F7629

P2093

Q36922577-418E2A09-78FB-42A5-84B9-BD1DCC66CB4B

Q36922577-66182797-4DFA-4EE3-B31C-9D8F1897D8CA

Q36922577-68BA998B-F11D-478D-A9AA-D79DB6753C85

Q36922577-8D3F1BAB-F55E-43D6-9068-74A61838D83A

Q36922577-A04F9454-8EF9-4E4F-BE51-B32276C791DB

Q36922577-A914B21D-A0BA-4D15-8C67-CA57A9388432

Q36922577-F1035AF7-99F3-4F40-8CEC-F0866F06E17C

P2860

Q36922577-069810EE-9501-43BD-9F60-A9829085C484

Q36922577-07926090-265F-4E62-BEBC-D663315E73A2

Q36922577-1E55A0C9-9073-4804-AACC-55A72D2A2ADC

Q36922577-2078A32F-DC8A-4302-819D-EF72849CEFD1

Q36922577-226D3181-1949-4441-B8F0-CA521BC38CD4

Q36922577-25479795-AD22-41DD-9235-DFA40CEFACB3

Q36922577-2704E9BA-C069-4D31-8E93-B3B67360EDB0

Q36922577-328BB21E-F00C-4BA1-9660-6D17D6CBC3C6

Q36922577-36AD29BE-01D3-4D6A-82FE-189BAC228088

Q36922577-36CF91C1-C530-42C4-A0D2-09AB8465DDF4

P304

Q36922577-8ED80264-C555-44C3-9917-F30E66CE3DFC

P31

Q36922577-72B5BFF7-0F89-4EE9-81B9-C03EA72A7A3E

P356

Q36922577-6E08692B-3950-4632-AEF0-CB895FB97D44

P407

Q36922577-F18C9FA9-7887-476D-BB93-CECC4653D724

P433

Q36922577-311120AF-0571-474D-A83E-F3F563BC934A

P478

Q36922577-745FD737-390F-4B9A-9DF7-0F2190937CEE

P577

Q36922577-C33775E8-03C5-4E5D-A6D1-CA24D4A22185

P698

Q36922577-AF6D3A03-A357-408F-ACCA-65A19EC62D65

P921

Q36922577-A698DDBB-FFE0-47A3-A0E5-54B2057E60F1

P932

Q36922577-87526846-63CB-4B4A-91A6-7F7CB086BE10

P356

JIMMUNOL.1203539

P1433

Journal of Immunology

P1476

Profound impairment of adaptive immune responses by alkylating chemotherapy

@en

P2093

Adam J Litterman

http://www.w3.org/2001/XMLSchema#string

Andres M Salazar

http://www.w3.org/2001/XMLSchema#string

Arkadiusz Z Dudek

http://www.w3.org/2001/XMLSchema#string

David M Zellmer

http://www.w3.org/2001/XMLSchema#string

John R Ohlfest

http://www.w3.org/2001/XMLSchema#string

Karen L Grinnen

http://www.w3.org/2001/XMLSchema#string

Matthew A Hunt

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of the ATM kinase by ionizing radiation and phosphorylation of p53

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

Estimating the precursor frequency of naive antigen-specific CD8 T cells

Phase I trial of temozolomide (CCRG 81045: M&B; 39831: NSC 362856)

Adoptive T cell therapy: Addressing challenges in cancer immunotherapy

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.

P304

6259-6268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1203539

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

190

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23686484

http://www.w3.org/2001/XMLSchema#string

P921

P932

3680135

http://www.w3.org/2001/XMLSchema#string